5 High ROE Stocks to Buy as Volatility Weighs on Markets

JAZZ Stock  USD 120.56  3.20  2.59%   
Slightly above 67% of Jazz Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Jazz Pharmaceuticals PLC stock suggests that many investors are alarmed at this time. Jazz Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Jazz Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
  
DIS, LDOS, RF, FTNT and JAZZ are some of the stocks with high ROE to profit from as intense volatility spooks markets.

Read at zacks.com
zacks News
  

Jazz Pharmaceuticals Fundamental Analysis

We analyze Jazz Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jazz Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jazz Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Shares Shorted

Number Of Shares Shorted Comparative Analysis

Jazz Pharmaceuticals is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Jazz Pharmaceuticals PLC Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jazz Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Jazz Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Jazz Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Jazz Pharmaceuticals Related Equities

INBXInhibrx   5.90   
0%
100.0%
LRMRLarimar Therapeutics   4.24   
0%
71.0%
TECHBio Techne   3.23   
0%
54.0%
LEGNLegend Biotech   3.02   
0%
51.0%
VRDNViridian Therapeutics   2.18   
0%
36.0%
DNLIDenali Therapeutics   2.02   
0%
34.0%
PCVXVaxcyte   1.87   
0%
31.0%
ASNDAscendis Pharma   1.74   
0%
29.0%
LQDALiquidia Technologies   1.57   
0%
26.0%
PTGXProtagonist Therapeutics   1.51   
0%
25.0%
BPMCBlueprint Medicines   1.32   
0%
22.0%
APLSApellis Pharmaceuticals   0.90   
0%
15.0%
RAREUltragenyx   0.85   
0%
14.0%
BMRNBiomarin Pharmaceutical   0.51   
0%
8.0%
ALNYAlnylam Pharmaceuticals   0.28   
0%
4.0%
ARGXArgenx NV   0.18   
0%
3.0%
INCYIncyte   0.14   
0%
2.0%
EXELExelixis   0.09   
0%
1.0%
HALOHalozyme Therapeutics   0.56   
9.0%
0%
UTHRUnited Therapeutics   1.08   
18.0%
0%

Additional Tools for Jazz Stock Analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.